Arvinas (ARVN) Short-term Investments (2016 - 2026)
Arvinas (ARVN) recorded Short-term Investments of $470.4 million in Q3 2026, down 31.4% from $686.1 million a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Short-term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Arvinas reported Short-term Investments of $542.5 million, down 42.2% from FY2024.
- Annual Short-term Investments has declined for four straight years, though with a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $938.9 million in FY2024 (-1.1%), $949.3 million in FY2023 (-15.5%), $1.12 billion in FY2022 (-19.4%) and $1.39 billion in FY2021.
- The Q3 2026 figure is the lowest quarterly Short-term Investments since Q1 2021.
- On a year-over-year basis, Short-term Investments has declined for eight consecutive quarters, with an average decline of 29.3% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 347.6% in Q1 2022, against a decline of 42.2% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $473.6 million (Q2 2026), $527.6 million (Q1 2026) and $542.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 470.40 Mn |
| Jun 30, 2026 | 473.60 Mn |
| Mar 31, 2026 | 527.60 Mn |
| Dec 31, 2025 | 542.50 Mn |
| Sep 30, 2025 | 686.10 Mn |
| Jun 30, 2025 | 746.30 Mn |
| Mar 31, 2025 | 873.30 Mn |
| Dec 31, 2024 | 938.90 Mn |
| Sep 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.08 Bn |
| Dec 31, 2023 | 949.30 Mn |
| Sep 30, 2023 | 884.80 Mn |
| Jun 30, 2023 | 948.20 Mn |
| Mar 31, 2023 | 993.30 Mn |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 1.37 Bn |
| Dec 31, 2021 | 1.39 Bn |
API Access
Arvinas Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();